Accretive Wealth Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-440
| Closed | -$238K | – | 133 |
|
|
2024
Q2 | $238K | Sell |
440
-4
| -0.9% | -$2.17K | 0.1% | 125 |
|
|
2024
Q1 | $234K | Hold |
444
| – | – | 0.1% | 127 |
|
|
2023
Q4 | $209K | Buy |
+444
| New | +$209K | 0.1% | 126 |
|
|
2023
Q2 | – | Sell |
-450
| Closed | -$207K | – | 115 |
|
|
2023
Q1 | $207K | Buy |
450
+15
| +3% | +$6.9K | 0.13% | 111 |
|
|
2022
Q4 | $223K | Sell |
435
-153
| -26% | -$78.5K | 0.15% | 105 |
|
|
2022
Q3 | $267K | Sell |
588
-31
| -5% | -$14.1K | 0.2% | 96 |
|
|
2022
Q2 | $299K | Sell |
619
-14
| -2% | -$6.76K | 0.22% | 97 |
|
|
2022
Q1 | $311K | Hold |
633
| – | – | 0.2% | 97 |
|
|
2021
Q4 | $293K | Buy |
633
+2
| +0.3% | +$926 | 0.19% | 97 |
|
|
2021
Q3 | $235K | Sell |
631
-13
| -2% | -$4.84K | 0.17% | 102 |
|
|
2021
Q2 | $246K | Sell |
644
-11
| -2% | -$4.2K | 0.18% | 101 |
|
|
2021
Q1 | $235K | Buy |
655
+30
| +5% | +$10.8K | 0.21% | 93 |
|
|
2020
Q4 | $201K | Buy |
+625
| New | +$201K | 0.2% | 94 |
|